GDX vs IBB

VanEck Gold Miners ETF vs iShares Biotechnology ETF

Quick take
  • IBB has the lower expense ratio at 0.44% vs 0.51% for GDX.
  • GDX pays a higher dividend yield (0.72%).

Side-by-side metrics

MetricGDXIBB
Expense ratio
Annual fee. Lower is better.
0.51%0.44%
Dividend yield
Trailing 12-month yield.
0.72%0.23%
AUM
Assets under management — bigger funds are typically more liquid.
$27.26B$7.95B
YTD return
7.78%3.10%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.740.74
P/E ratio
17.9223.72
Last price
$91.72$170.10
Inception
Issuer
VanEckiShares

GDX top holdings

Top holdings · GDX
AEM.TOAgnico Eagle Mines Ltd11.54%
NEMNewmont Corp11.31%
ABX.TOBarrick Mining Corp7.60%
FNV.TOFranco-Nevada Corp5.05%
AUAnglogold Ashanti PLC5.00%
WPM.TOWheaton Precious Metals Corp4.93%
K.TOKinross Gold Corp4.84%
GFIGold Fields Ltd ADR4.33%
PAAS.TOPan American Silver Corp3.17%
NST.AXNorthern Star Resources Ltd2.89%
Sector breakdown · GDX
Basic Materials100.0%

IBB top holdings

Top holdings · IBB
AMGNAmgen Inc7.37%
GILDGilead Sciences Inc7.32%
VRTXVertex Pharmaceuticals Inc7.21%
REGNRegeneron Pharmaceuticals Inc6.55%
ALNYAlnylam Pharmaceuticals Inc3.71%
ARGXargenx SE ADR3.33%
INSMInsmed Inc2.70%
BIIBBiogen Inc2.67%
NTRANatera Inc2.40%
RVMDRevolution Medicines Inc Ordinary Shares2.27%
Sector breakdown · IBB
Healthcare100.0%

About GDX

GDX (VanEck Gold Miners ETF) is Major gold mining companies. Managed by VanEck, the fund carries $27.3B in assets under management, an expense ratio of 0.51%, a dividend yield of 0.72%. Its largest holding is Agnico Eagle Mines Ltd (AEM.TO), which represents 11.5% of the portfolio. Basic Materials is the fund's largest sector exposure at 100.0%.

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.